All In Biotech

Drug Trial Radar · NCT00050960

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Last checked: Nov 20, 2026Latest source record: Jul 13, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 612 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

612

Actual

Start

May 2002

Primary completion

Jul 2004

Study completion Mar 2005

Sponsor

Lead sponsor
Eisai Inc.Eisai
Sponsor type
Industry
First posted
Jan 3, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.

Conditions

  • Non-small Cell Lung Cancer

Interventions

  • bexarotene with carboplatin and paclitaxelDrug

    bexarotene capsules (400 mg/m\^2/day) in combination with carboplatin IV (AUC 6) every 3 weeks and paclitaxel IV (200 mg/m\^2) every 3 weeks. Subjects in this group also received an antilipid agent which was selected at the discretion of the investigator.

  • carboplatin and paclitaxelDrug

    carboplatin IV (AUC 6) every 3 weeks and paclitaxel IV (200 mg/m\^2) every 3 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: From date of randomization to date of death

Locations

154 sites in 6 countries. Site status is shown where the registry gives one.

  • Montgomery Cancer Center, L.L.C.

    Montgomery, Alabama

  • Arizona Clinical Research Center, Inc.

    Tucson, Arizona

  • Bay Area Cancer Research Group, LLC

    Concord, California

  • Compassionate Cancer Care Medical Group, Inc.

    Fountain Valley, California

  • Pacific Coast Hematology/Oncology Medical Group, Inc.

    Fountain Valley, California

  • California Cancer Care, Inc.

    Greenbrae, California

  • Coast Hematology and Oncology Associates

    Long Beach, California

  • Metropolitan Hematology/Oncology Medical Group

    Los Angeles, California

  • Sant P. Chawla, Inc.

    Los Angeles, California

  • UCLA Medical Center

    Los Angeles, California

  • Sutter Gould Medical Foundation

    Modesto, California

  • Medical Oncology Care Associates

    Orange, California

  • Southern California Kaiser Permanente Medical Group

    San Diego, California

  • Sharp Health Care

    San Diego, California

  • UCSF/Mount Zion Comprehensive Cancer Center

    San Francisco, California

  • Medical Group of North County, Inc., San Diego Cancer Center

    Vista, California

  • Rocky Mountain Cancer Centers - Midtown

    Denver, Colorado

  • Eastern Connecticut Hematology & Oncology

    Norwich, Connecticut

  • Georgetown University Hospital

    Washington D.C., District of Columbia

  • Washington Cancer Institute

    Washington D.C., District of Columbia

  • Comprehensive Cancer Care Specialists of Boca Raton

    Boca Raton, Florida

  • University of Florida/Jacksonville

    Jacksonville, Florida

  • Watson Clinic

    Lakeland, Florida

  • Oncology and Radiation Associates

    Miami, Florida

  • Florida Cancer Institute

    New Port Richey, Florida

  • Florida Oncology Associates

    Orange Park, Florida

  • Cancer Centers of Florida, P.A.

    Orlando, Florida

  • South Florida Oncology & Hematology Consultants

    Plantation, Florida

  • Medical Oncology Associates of Augusta

    Augusta, Georgia

  • Georgia Oncology Partners Research & Education Foundation

    Marietta, Georgia

  • St. Luke's/Mountain State Tumor Institute (MSTI)

    Boise, Idaho

  • Weiss Memorial Hospital

    Chicago, Illinois

  • Northwest Oncology and Hematology, SC

    Elk Grove Village, Illinois

  • Lutheran General Cancer Care Center

    Park Ridge, Illinois

  • Oncology/Hematology Associates of Central Illinois, P.C.

    Peoria, Illinois

  • Hematology Oncology Assoc. of Illinois

    Skokie, Illinois

  • Central Indiana Cancer Centers

    Indianapolis, Indiana

  • Cancer Care Center

    New Albany, Indiana

  • Michiana Hematology-Oncology

    South Bend, Indiana

  • Kansas City Oncology and Hematology Group, Kansas City Cancer Centers

    Overland Park, Kansas

Showing 40 of 154 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.